FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a method for producing remdesivir, including interaction in the presence of a nucleoside base of formula (II)
where R1 and R2 together or separately represent H or a protective group, with the phosphoramidate of formula (III)
where X represents and also the removal of the protective group, if R1 and R2 together are not H. Also, the invention relates to phosphoramidates of formula III.
EFFECT: present invention makes it possible to obtain remdesivir with high yield, chemical and optical purity, using the simplicity of the technology.
6 cl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS OF TREATING CORONAVIRUS INFECTIONS | 2021 |
|
RU2825648C1 |
APPLICATION OF AN OXYGEN-CONTAINING DERIVATIVE OF 6-HALOQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2, AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2780245C1 |
METHOD FOR PREVENTION OR TREATMENT OF CORONAVIRUS AND OTHER ACUTE RESPIRATORY VIRAL INFECTIONS | 2022 |
|
RU2794315C1 |
METHOD OF PRODUCING SOFOSBUVIR AND PHOSPHORAMIDATES | 2020 |
|
RU2740058C1 |
APPLICATION OF A TRICYCLIC SULPHUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2 | 2021 |
|
RU2780247C1 |
PHARMACEUTICAL COMPOSITION, INCLUDING TRICYCLIC SULFUR-CONTAINING 1,2-DIHYDROQUINOLINE DERIVATIVE FOR INHIBITION OF REPLICATION OF BETA CORONAVIRUSES, INCLUDING SARS-CoV-2, AND METHOD OF ITS USE | 2021 |
|
RU2814434C1 |
METHOD OF PRODUCING A TRICYCLIC SULFUR-CONTAINING DERIVATIVE OF 1,2-DIHYDROQUINOLINE FOR INHIBITING REPLICATION OF BETA-CORONAVIRUSES, INCLUDING SARS-CoV-2 | 2021 |
|
RU2819783C1 |
APPLICATION OF A DERIVATIVE OF 1,3,5-TRIAZINE-2,4-DIAMINE FOR INHIBITING THE REPLICATION OF BETACORONAVIRUSES, INCLUDING SARS-COV-2 | 2021 |
|
RU2780249C1 |
METHOD FOR PREPARING A THIO DERIVATIVE OF PYRROLIDINE-2,5-DIONE WITH A QUINAZOLINE FRAGMENT | 2021 |
|
RU2807057C2 |
INDOLE-3-CARBOXYLIC ACID DERIVATIVE HAVING ANTIVIRAL ACTIVITY ON SARS-CoV-2 | 2022 |
|
RU2820633C1 |
Authors
Dates
2021-10-07—Published
2020-11-20—Filed